# Clinical Trial Eligibility Assessment - Prostate Cancer

A comprehensive data analytics portfolio project demonstrating clinical trial feasibility workflows used in pharmaceutical and biotechnology companies. This analysis evaluates patient recruitment potential for Abbott's non-metastatic prostate cancer trial using synthetic electronic health record (EHR) data.

## Project Overview
- **Therapeutic Area:** Non-metastatic prostate cancer
- **Trial Protocol:** NCT00036556 (Abbott Laboratories)
- **Dataset:** 5,000 synthetic patients (Synthea), 28 living prostate cancer patients
- **Tools:** PostgreSQL, SQL, Power BI, pgAdmin4
- **Key Finding:** 0% recruitment feasibility due to prior chemotherapy exclusion

## Skills Demonstrated
- Complex SQL queries for patient cohort identification
- Multi-table joins and data modeling
- Healthcare terminology (SNOMED CT codes)
- Inclusion/exclusion criteria logic
- Data visualization and executive reporting
- Clinical domain expertise and analytical thinking
